IP Library Granted Patent US 8,620,423
Granted Patent B2
US 8,620,423 · App. 13/047,094 · Granted Dec 31, 2013

Methods for thermal modulation of nerves contributing to renal function

Inventors: Denise Demarais (Saratoga, CA); Hanson Gifford, III (Woodside, CA)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,620,423
App. No.
13/047,094
Granted
Dec 31, 2013
Kind
B2
Abstract

Methods and apparatus are provided for treatment of heart arrhythmia via renal neuromodulation. Such neuromodulation may effectuate irreversible electroporation or electrofusion, ablation, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, such neuromodulation is achieved through application of an electric field. In some embodiments, such neuromodulation is achieved through application of neuromodulatory agents, of thermal energy and/or of high intensity focused ultrasound. In some embodiments, such neuromodulation is performed in a bilateral fashion.

Claims (30)

1. A method for catheter-based renal denervation, the method comprising:

positioning a neuromodulation element within a renal blood vessel of a human patient; and

ablating nerves that innervate a kidney of the patient from within the renal blood vessel via the neuromodulation element.

2. The method of claim 1 wherein ablating nerves that innervate a kidney of the patient further comprises altering at least one of urine production, fluid retention, renin secretion, waste excretion, sodium retention, systemic vasoconstriction, renal function, heart function, and blood pressure in the patient.

3. The method of claim 2 wherein altering urine production comprises increasing urine output.

4. The method of claim 2 wherein altering renin secretion comprises decreasing plasma renin levels.

5. The method of claim 2 wherein altering sodium retention comprises increasing sodium excretion.

6. The method of claim 1 wherein ablating nerves that innervate a kidney of the patient comprises further comprises systemically reducing sympathetic tone in the patient.

7. The method of claim 1 wherein positioning a neuromodulation element within a renal blood vessel comprises intravascularly positioning the neuromodulation element within a renal artery of the patient.

8. The method of claim 1 wherein positioning a neuromodulation element within a renal blood vessel comprises intravascularly positioning the neuromodulation element within a renal vein of the patient.

9. The method of claim 1 wherein ablating nerves that innervate a kidney of the patient comprises ablating at least one of an efferent neural fiber and an afferent neural fiber with the neuromodulation device.

10. The method of claim 1 wherein ablating nerves that innervate a kidney of the patient comprises at least partially denervating the kidney.

11. The method of claim 1 wherein ablating nerves that innervate a kidney via the neuromodulation element comprises thermally ablating the nerves from within the renal blood vessel.

12. The method of claim 11 wherein thermally ablating the nerves from within the renal blood vessel comprises thermally ablating the nerves using radiofrequency energy.

13. The method of claim 11 wherein thermally ablating the nerves from within the renal blood vessel comprises thermally ablating the nerves using microwave energy.

14. The method of claim 11 wherein thermally ablating the nerves from within the renal blood vessel comprises thermally ablating the nerves using ultrasound energy.

15. The method of claim 11 wherein thermally ablating the nerves from within the renal blood vessel comprises cooling the nerves that innervate the kidney of the patient.

16. The method of claim 1 wherein ablating nerves that innervate a kidney of the patient from within the renal blood vessel comprises delivering a neuromodulatory agent to the nerves.

17. The method of claim 1 wherein ablating nerves that innervate a kidney of the patient from within the renal blood vessel comprises ablating the nerves via at least one wall-contacting electrode.

18. The method of claim 1 wherein the neuromodulation element comprises an expandable element having a plurality of electrodes and configured to expand from a low profile configuration to a wall contact configuration, and wherein:

positioning a neuromodulation element within a renal blood vessel of a patient comprises positioning the neuromodulation element within the renal blood vessel in the low profile configuration and expanding the neuromodulation element to the wall contact configuration at a desired treatment site; and

ablating nerves that innervate a kidney via the neuromodulation element comprises creating multiple ablation zones along the renal blood vessel of the patient via the electrodes of the neuromodulation element.

19. The method of claim 1 wherein positioning a neuromodulation element within a patient comprises positioning the neuromodulation element in a patient diagnosed with heart arrhythmia, and wherein the heart arrhythmia comprises at least one of the following: atrial arrhythmia, ventricular arrhythmia, tachycardia, bradycardia, atrial tachycardia, atrial fibrillation, atrial flutter, supraventricular tachycardia, Wolff-Parkinson-White syndrome, ventricular tachycardia, ventricular fibrillation, long QT syndrome, sick sinus, and conduction block.

20. The method of claim 1 , further comprising controlling the ablation of the nerves in response to a monitored parameter.

21. The method of claim 20 wherein the neuromodulation element further comprises a sensor configured to monitor at least one of temperature and impedance, and wherein controlling the ablation of the nerves in response to the monitored parameter comprises controlling the ablation based on the monitored temperature and/or impedance.

22. A method for renal nerve ablation of a human patient, the method comprising:

intravascularly delivering a modulation device to a vicinity of a renal nerve of the patient; and

thermally ablating the renal nerve from within a renal blood vessel of the patient via the modulation device.

23. The method of claim 22 wherein thermally ablating the renal nerve further comprises decreasing a load on a heart of the patient.

24. The method of claim 22 wherein thermally ablating the renal nerve from within the renal blood vessel via the modulation device comprises thermally ablating the renal nerve via a wall-contacting electrode.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2013
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 030531/0717 →
CHANGE OF NAME Recorded Jun 3, 2013
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 030531/0816 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2011
From: DEMARAIS, DENISE; GIFFORD, HANSON, III
To: ARDIAN, INC.
Reel/Frame 025951/0288 →
Continuity (20)
Continuation 12725375 · Mar 16, 2010
Continuation 11599882 · Nov 14, 2006
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11133925 · May 20, 2005
Continuation 10900199 · Jul 28, 2004
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 11266993 · Nov 4, 2005
Continuation In Part 11363867 · Feb 27, 2006
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11266993
Continuation In Part 11504117 · Aug 14, 2006
Provisional Application 60442970 · Jan 29, 2003
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60813589 · Dec 29, 2005
Related Publication 20110257564A1 · Oct 20, 2011